Comprehensive information for the use of antiretroviral preexposure prophylaxis (PrEP) to prevent acquiring HIV infection.
Updates for 2021 include:
A recommendation to inform all sexually active adults and adolescents about PrEP
PrEP with intramuscular cabotegravir (CAB) injections (conditional on FDA approval) is recommended for HIV prevention in adults reporting sexual behaviors that place them at substantial ongoing risk of HIV exposure and acquisition.
Comprehensive information for the use of antiretroviral preexposure prophylaxis (PrEP) to prevent acquiring HIV infection.
Updates for 2021 include:
A recommendation to inform all sexually active adults and adolescents about PrEP
PrEP with intramuscular cabotegravir (CAB) injections (conditional on FDA approval) is recommended for HIV prevention in adults reporting sexual behaviors that place them at substantial ongoing risk of HIV exposure and acquisition.
Perinatal HIV and Congenital Syphilis—Dear Colleague Letter from CDPH
November 16, 2021: CDPH is asking for assistance in responding to concerning increases in congenital syphilis and perinatal HIV in California. Perinatal HIV transmission and congenital syphilis can be prevented with timely testing and treatment. A common risk factor, however, is receiving late or no prenatal care.
CDPH requests your assistance to implement the following policies and best practices to Screen, Treat and Prevent, and Prepare for perinatal transmissions
Current evidence-based prevention, diagnostic and treatment recommendations that replace the 2015 STI treatment guidance. Although the guidelines emphasize treatment, prevention strategies and diagnostic recommendations also are discussed.
Current evidence-based prevention, diagnostic and treatment recommendations that replace the 2015 STI treatment guidance. Although the guidelines emphasize treatment, prevention strategies and diagnostic recommendations also are discussed.
California Clinical Guidelines for Gonorrhea Treatment and Management of Suspected Treatment Failure
This guideline summarizes the California Department of Public Health (CDPH) clinical recommendations to enhance detection and management of suspected gonorrhea treatment failure and assure adequate treatment.
This guideline summarizes the California Department of Public Health (CDPH) clinical recommendations to enhance detection and management of suspected gonorrhea treatment failure and assure adequate treatment.
Disseminated Gonococcal Infection in CA—Dear Colleague letter from CDPH
December 23, 2020: CDPH requests medical providers should reinstate routine screening recommendations for STDs in females <25 years of age, pregnant females, men who have sex with men and individuals with HIV. Providers should increase their clinical suspicion for DGI in patients with joint pain and undertake the following additional actions.
Guidance and procedures from the American College of Obstetricians and Gynecologists (ACOG) about the COVID-19 vaccine for pregnant and lactating individuals.
We use cookies to ensure that we give you the best experience on our website, but we also recognize the right to privacy. Please accept or disable cookies for this website.
